Berger W
Horm Metab Res Suppl. 1985;15:111-5.
The most important side-effect of sulfonylureas is hypoglycaemia. According to surveys in Switzerland and in Sweden it occurs at a frequency of about 2 cases per 10,000 treatment years. Mortality is high, about 10%. The syndrome of inappropriate ADH-secretion has been observed almost exclusively during treatment with chlorpropamide. Asymptomatic cases of SIADH-syndrome are quite frequent, hyponatraemia has been observed in 6-10% of diabetics treated with chlorpropamide. The most dangerous side-effect of biguanides is lactic acidosis. It occurs significantly more frequent during treatment with phenformin compared to metformin. Metformin has been reported to lead to lactic acidosis in 0.4 cases per 10,000 treatment years; mortality is about 30%. Mortality of phenformin-associated lactic acidosis is even higher, 70%. Both biguanides, phenformin and metformin, cause relatively frequently vitamin B12-malabsorption (in about 1/3 of the cases). However, symptomatic vitamin B12-deficiency is extremely rare.
磺脲类药物最重要的副作用是低血糖。根据瑞士和瑞典的调查,其发生率约为每10000治疗年2例。死亡率很高,约为10%。抗利尿激素分泌异常综合征几乎仅在使用氯磺丙脲治疗期间观察到。无症状的抗利尿激素分泌异常综合征病例相当常见,在用氯磺丙脲治疗的糖尿病患者中,6% - 10%出现低钠血症。双胍类药物最危险的副作用是乳酸性酸中毒。与二甲双胍相比,苯乙双胍治疗期间乳酸性酸中毒的发生率明显更高。据报道,二甲双胍导致乳酸性酸中毒的发生率为每10000治疗年0.4例;死亡率约为30%。苯乙双胍相关乳酸性酸中毒的死亡率更高,为70%。苯乙双胍和二甲双胍这两种双胍类药物都相对频繁地导致维生素B12吸收不良(约1/3的病例)。然而,有症状的维生素B12缺乏极为罕见。